Epitome Biosystems™

Highly parallel quantitative measurement of protein biomarkers and intracellular protein signalling pathways using antibody microarrays

Epitome Biosystems™ was founded in 2004 by experts in the field of proteomic analysis. Backed by Flagship Ventures in Cambridge, MA, and with an outstanding Scientific Advisory Board, Epitome is set to become a world leader in multiplex protein analysis.

Neal Gordon (President)
Jeffrey A. Radding (VP, R&D)
Kellie Watson (VP, Business Development)
Edward T. Machuga (VP, Sales and Marketing)

Neal Gordon (President)
Edwin Kania
Daniel Wang
Harry Wilcox

Ruedi Aebersold
Noubar B. Afeyan
Joseph Davie
Richard DiMarchi
Sam Hanash
Joseph Jacobson
Thomas Joos
Douglas Lauffenburger
Forest White

Epitome Biosystems™
100 Beaver Street
Waltham, MA 02453
USA
Phone: +1-781-891-3816
Fax: +1-781-891-3843

EpiTag™ technology makes use of the fundamental insight that every protein can be uniquely identified based on short, continuous stretches of amino acid sequence. Epitome Biosystems™ uses a proprietary informatics approach to identify the EpiTags™ from sequence information.